Excelra

Excelra Excelra accelerates drug discovery & development leveraging advanced data science technologies and d

Excelra's data and analytics solutions empower innovation in life sciences across the value chain from discovery to market. The Excelra Edge comes from a seamless amalgamation of proprietary curated data assets, deep domain expertise and data science. The company's multifaceted teams harmonize and analyze large volumes of disparate unstructured data using cutting-edge technologies. We galvanize data-driven decisions to unlock operational efficiencies to accelerate drug discovery and development. Over the past 18 years, Excelra has been the preferred data and analytics partner to over 90 global clients including 15 of the top 20 large Pharma companies.

  | What if integrating gene expression and WES data could uncover biomarkers driving immunotherapy resistance? Here’s h...
20/10/2025

| What if integrating gene expression and WES data could uncover biomarkers driving immunotherapy resistance?

Here’s how Excelra turned complex genomic data into actionable biomarker insights: https://na2.hubs.ly/H01Fp9k0

We integrated Whole Exome Sequencing (WES) and gene expression profiles to identify biomarker signatures linked to immunotherapy efficacy and resistance in Small Cell and Renal Cell Carcinoma.

By combining somatic mutation data with transcriptomic insights using tools like Paradigm-shift, DriverNet, and DawnRank, key biological themes and pathway mechanisms were uncovered.

The outcome? validated biomarker signatures, network modules, and functional mutations that accelerate biomarker discovery and enable precision-driven immunotherapy research.

We’re excited to share that Excelra will be speaking at the Chem-Bio Informatics Society (CBI) Annual Meeting 2025!Join ...
17/10/2025

We’re excited to share that Excelra will be speaking at the Chem-Bio Informatics Society (CBI) Annual Meeting 2025!

Join Uzma Saeed, Group Head – Bioinformatics, on 29th Oct 2025 | 12:00–13:00 PM JST, for the LS04-01 Luncheon Seminar, presented in collaboration with Patcore Inc.

Uzma will be speaking on “Transforming Therapeutics: A Mechanism-Based Approach to Drug Discovery” — highlighting how mechanism-based insights and data-driven bioinformatics are reshaping the future of therapeutics discovery and development.

📍 Zuiun 2F (144), 4-1-1 Funabori, Edogawa-ku, Tokyo

Is your R&D data growing faster than you can make sense of it? Discover how to turn that challenge into an advantage: ht...
16/10/2025

Is your R&D data growing faster than you can make sense of it?
Discover how to turn that challenge into an advantage: https://na2.hubs.ly/H01Dv5K0

In biopharma, vast amounts of data often end up fragmented—slowing discovery, delaying approvals, and hiding millions in lost value.

That’s where FAIR—Findable, Accessible, Interoperable, and Reusable—comes in. It’s not an instant fix but a long-term transformation.

In this whitepaper, Excelra shares two decades of experience helping organizations turn raw data into a strategic asset for AI-driven R&D. FAIR adoption has:
• Cut re-submission cycles by 25%
• Improved data findability by 40%
• Reduced duplicate experiments by 25%
• Fueled 15+ publications

Download the whitepaper to see how Excelra operationalizes FAIR and future-proofs R&D data ecosystems.

&D &DInnovation

14/10/2025

| What if cell line validation could be 90% faster, without losing accuracy?
https://www.excelra.com/case-studies/biomarker-cell-line/

By uncovering lineage-specific, PCR-validatable biomarkers, Excelra removed the need for repetitive whole genome sequencing, creating a rapid, scalable QC system that preserves full WGS precision.

This approach transformed routine lineage validation — timelines that once took weeks now take hours, while maintaining >98% accuracy, cutting operational costs by over 70%, and boosting QC throughput 5x.

With this scalable framework, teams can accelerate decision-making, enhance traceability, and scale quality control without compromise.

  | What if we could predict which patients respond to treatment before the first trial dose? https://na2.hubs.ly/H01vtb...
09/10/2025

| What if we could predict which patients respond to treatment before the first trial dose? https://na2.hubs.ly/H01vtbM0

In oncology, patient response often remains an unknown variable, slowing timelines, increasing costs, and adding uncertainty to trial outcomes. Identifying the right biomarkers early can change that.

Excelra’s biomarker-driven approach:
Analyzed gene-expression data
Applied ML and pathway enrichment
Stratified patients to predict response

The result? 8 biomarkers identified, 82% prediction accuracy, and new opportunities for subtype analysis and IO combinations.

We are excited to sponsor the Pistoia Alliance’s Data Driven Innovations Conference, November 11–12, 2025. Read more: ht...
08/10/2025

We are excited to sponsor the Pistoia Alliance’s Data Driven Innovations Conference, November 11–12, 2025. Read more: https://na2.hubs.ly/H01t0_50

Discover how Excelra’s innovations in agentic AI, smart data, digital trials, and the 3Rs are transforming life sciences R&D and enabling faster, smarter, and more efficient research.

Stop by to connect with our experts, exchange insights, and explore opportunities to accelerate discovery and drive innovation forward.

&D

What an exciting Day 1 at BioTechX Europe 2025!A big thank you to everyone who stopped by and connected with our team.We...
07/10/2025

What an exciting Day 1 at BioTechX Europe 2025!
A big thank you to everyone who stopped by and connected with our team.

We’re looking forward to day 2, come say hi at Booth #215 and chat with our experts about how Excelra’s solutions are transforming drug discovery.

Ever wondered why some siRNA & oligo therapeutics take years to reach the clinic, despite their groundbreaking potential...
06/10/2025

Ever wondered why some siRNA & oligo therapeutics take years to reach the clinic, despite their groundbreaking potential?

The answer lies in complex workflows: fragmented systems, manual sample mapping, and limited cross-team collaboration create delays at every stage of development.

Digitalization is bridging these gaps. From automated sequence design to real-time assay dashboards, modern solutions help researchers streamline processes, reduce errors, and accelerate discoveries.

Read our latest blog to see how Excelra leverages bioinformatics and scientific informatics to enhance workflows and bring precision medicine closer to patients: https://na2.hubs.ly/H01lHm60

We’re excited to share that Excelra will be speaking at PLA® USA Conference 2025!🔗 https://na2.hubs.ly/H01mDmw0 Join Nor...
03/10/2025

We’re excited to share that Excelra will be speaking at PLA® USA Conference 2025!
🔗 https://na2.hubs.ly/H01mDmw0

Join Norman Azoulay, VP – Platforms & Data, on 7th Oct 2025 | 11:40 AM – 12:00 PM, as he dives into "Turning Complex Data into Trusted Insights with Data products and LLMs"

From handling large-scale data across multiple platforms to implementing intelligent workflows with LLMs, Norman will share how Excelra is enabling life sciences teams to make faster, more informed decisions and accelerate innovation.

See you at the conference!

Meet our experts at Paperless Lab Academy® (PLA) USA 2025!Click here to schedule a meeting: https://na2.hubs.ly/H01mDmG0...
01/10/2025

Meet our experts at Paperless Lab Academy® (PLA) USA 2025!
Click here to schedule a meeting: https://na2.hubs.ly/H01mDmG0

Visit us at The Florida Hotel, Orlando, Florida, USA, on October 5–7, 2025, and discover how Excelra’s agile, scalable, and compliant informatics solutions are helping labs accelerate digital maturity.

Connect with our experts to explore solutions that streamline lab workflows and enhance compliance.

Meet our experts at BioTechX Europe 2025!Click here to schedule a meeting: https://na2.hubs.ly/H01lHPL0 Visit us at Boot...
30/09/2025

Meet our experts at BioTechX Europe 2025!
Click here to schedule a meeting: https://na2.hubs.ly/H01lHPL0

Visit us at Booth #215 on October 6–8 at Messe, Basel, Switzerland, and explore how Excelra’s innovative bioinformatics and scientific informatics solutions are transforming drug discovery and development.

Connect with our experts to explore solutions that address your needs and drive innovation.

  | Can AI and ML turn digital biomarkers into real-time, actionable insights? https://na2.hubs.ly/H01gJHC0 Digital biom...
26/09/2025

| Can AI and ML turn digital biomarkers into real-time, actionable insights?
https://na2.hubs.ly/H01gJHC0

Digital biomarkers are no longer futuristic they enable continuous, non-invasive monitoring through wearables and mobile apps.

Excelra leverages this AI/ML-driven analysis on multi-omics and real-time data to identify predictive biomarkers, accelerating drug discovery, development, and personalized medicine.

The Impact!
Real-time monitoring, earlier detection, and smarter interventions, bringing precision medicine closer to reality.

Address

Uppal

Opening Hours

Monday 9am - 6pm
Tuesday 9am - 6pm
Wednesday 9am - 6pm
Thursday 9am - 6pm
Friday 9am - 6pm

Telephone

+91 40 6707 3333

Alerts

Be the first to know and let us send you an email when Excelra posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Excelra:

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram